2013, Heart Failure and Outcomes - Cardiovascular Update

BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention

Open Heart

DECEMBER 7, 2023

Objective This study aimed to investigate the association between heart failure (HF) severity measured based on brain natriuretic peptide (BNP) levels and future bleeding events after percutaneous coronary intervention (PCI). The secondary outcome was major adverse cardiovascular events (MACE).

Heart Failure

Heart Failure Academic Risk Factors Hospital

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

JANUARY 29, 2024

years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 The primary focus was on 5-year survival rates.

Aortic valve

Aortic valve TAVR Aortic Outcomes

Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure for Clinical Phenotypes

Circulation: Cardiovascular Quality & Outcomes

JANUARY 27, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:The absence of practice standards in vasoactive agent usage for acute decompensated heart failure has resulted in significant treatment variability across hospitals, potentially affecting patient outcomes. in 2013 to 48.6% to 77.8%.

Heart Failure

Heart Failure Hospital Pulmonary Laboratory

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry

Circulation: Cardiovascular Interventions

MARCH 17, 2025

In multivariable analyses, the risk of 1-year heart failure readmission for ventricular functional MR was not higher than for DMR (P=0.10642), while patients with chronic ischemic MR and atrial MR had a 19% higher risk of 1-year heart failure readmission compared with DMR (P=0.00493) even if they had a successful procedure.

Bicuspid/Mitral

Bicuspid/Mitral Outcomes Heart Failure Cardiovascular Interventions

Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry

European Journal of Heart Failure

DECEMBER 13, 2023

ACEi, angiotensin-converting-enzyme inhibitor; BB, beta blocker; CV, cardiovascular; HF, heart failure; MRA, mineralocorticoid receptor antagonist; RHR, resting heart rate; SBP, systolic blood pressure. Complete follow-up data were available for 5138 patients. 2.21, p < 0.001), cardiovascular death (HR 2.70, 95% CI 1.69–4.33,

Blood Pressure

Blood Pressure Heart Failure Hospital Risk Factors

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

JULY 24, 2024

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Am J Cardiol 2013; 112:1142–1147. 1 Approximately 33 million patients worldwide are living with AFib.

Atrial Fibrillation

Atrial Fibrillation AFIB Ablation Technology

Abstract 4140019: Emergency or Non-referral Admission Was Associated with Poor Outcomes in Adults Hospitalized for the Treatment of Cardiovascular Comorbidities in Congenital Heart Diseases: Analysis of the Nationwide Claim-based Dataset from The Japanese Registry of all Cardiac and Vascular Diseases-Diagnosis Procedure Combination

Circulation

NOVEMBER 11, 2024

Introduction:The number of adults with congenital heart diseases (CHD) is rapidly increasing, who are frequently associated with cardiovascular morbidities and may result in poor outcomes. Outcome measures included total hospital deaths (5.0%).

Congenital Heart Disease

Congenital Heart Disease Congenital Hospital Heart Disease

Overcoming Status Quo Bias: Embracing Evidence-Based Guidelines in Cardiometabolic Care

Cardiometabolic Health Congress

AUGUST 30, 2024

This discussion explores the principles and practices of evidence-based cardiometabolic medicine, emphasizing the importance of integrating the latest research findings into clinical decision-making to improve patient outcomes. Heart Failure : Home-based cardiac rehabilitation is as effective as center-based programs.

Cardiac Rehabilitation

Cardiac Rehabilitation Heart Failure Quality of Life Aortic

Percutaneous Revascularisation for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 6, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. The REVIVED-BCIS2 trial concluded that PCI did not reduce the incidence of all-cause death or heart failure (HF) hospitalization, however patients assigned to PCI reported better initial health-related quality of life than those assigned to optimal medical therapy (OMT) alone.

Quality of Life

Quality of Life Heart Failure Hospital Outcomes

Additional Data From SEQUOIA-HCM Presented at HFSA Annual Scientific Meeting

DAIC

OCTOBER 2, 2024

vs 24% showed enhanced exercise capacity and 84% vs 8% demonstrated a substantial response in cardiac biomarkers (for all p aficamten achieved one or more clinically relevant outcomes, 62% achieved at least three outcomes and 23% achieved all four outcomes. CVrg: Heart Failure 2020-2029, p 44; Maron et al.

Cardiomyopathy

Cardiomyopathy Sudden Cardiac Death Biomarkers Heart Failure

Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity

Circulation: Heart Failure

JANUARY 26, 2024

Circulation: Heart Failure, Ahead of Print. CONCLUSIONS:Bariatric surgery and pharmacotherapies with weight loss effects are associated with a lower risk of adverse outcomes among older patients with HF and obesity; however, overall utilization remains low. In propensity-matched analysis over a median follow-up of 2.8

Heart Failure

Heart Failure Obesity Outcomes Medicare

Identification of Fatigue Subtypes and Their Correlates in Prevalent Heart Failure: A Secondary Analysis of the Atherosclerosis Risk in Communities Study

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Among patients with heart failure (HF), fatigue is common and linked to quality of life and functional status. Unique subtypes of fatigue in HF may require differential assessment and treatment to improve outcomes.

Atherosclerosis

Atherosclerosis Heart Failure Quality of Life Education

Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction

Open Heart

APRIL 6, 2022

Methods All patients, registered in the Norwegian Myocardial Infarction Registry (NORMI) between 2013 and 2019 with ECG-verified AF at hospitalisation, were included in the cohort study. The primary outcome was the prescription rate of anticoagulation therapy at hospital discharge and follow-up through 2019. 95% CI 0.7 95% CI 0.7

Myocardial Infarction

Myocardial Infarction Atrial Fibrillation Heart Failure Strokes

Incidence, Risk Factors, and Outcomes Associated With Permanent Pacemaker Implantation Following Tricuspid Valve Surgery

Journal of the American Heart Association

JANUARY 31, 2024

We sought to evaluate its incidence, risk factors, and outcomes.Methods and ResultsMedicare beneficiaries who underwent TVS from 2013 to 2020 were identified. Outcomes included all‐cause mortality and readmission with endocarditis or heart failure on follow‐up. Patients who underwent TVS for endocarditis were excluded.

Risk Factors

Risk Factors Tricuspid Pacemaker Outcomes

The legal case – naming a few names

Dr. Malcolm Kendrick

OCTOBER 30, 2024

In 2013 Kellogg’s funded British research that concluded “regular consumption of cereals might help children stay slimmer.” Assessing the potential for SenseCam to fight the current global health crises of increasing obesity and physical inactivity (2010-2013) Microsoft: £69K ATLAS trial of tamoxifen duration (1997-2018) AstraZeneca: £1.0M

Cholesterol

Cholesterol Article Research Diet

Chest pain followed by 6 days of increasing dyspnea -- what happened?

Dr. Smith's ECG Blog

FEBRUARY 26, 2025

Incidence and Prognosis of Pericarditis After ST-Elevation Myocardial Infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database). References: [1] Lador, A. The American Journal of Cardiology , 121 (6), 690694. link] [2] Oliva, P. Hammill, S. & Edwards, W. Physical Exam was revealing.

Chest Pain

Chest Pain Pericarditis Myocardial Infarction Dementia

Patient is informed of her husband's death: is it OMI or it stress cardiomyopathy?

Dr. Smith's ECG Blog

MARCH 8, 2025

Was her outcome to be expected for ostial RCA OMI? In addition to profound acute heart failure, the patient suffered from electrical storm. There is no specific treatment for stress cardiomyopathy, only supportive treatment. Or was it out of proportion, perhaps worsened by the sympathetic surge? We will never know for certain.

Cardiomyopathy

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia

Right ventricular dysfunction and impaired right ventricular–pulmonary arterial coupling in paradoxical low‐flow, low‐gradient aortic stenosis

European Journal of Heart Failure

DECEMBER 19, 2024

While left ventricular (LV) systolic function is preserved, right ventricular dysfunction (RVD) and consecutive LV underfilling may contribute to low-flow and reduced stroke volume index, and to adverse outcomes following transcatheter aortic valve implantation (TAVI).

Stenosis

Stenosis Aortic Pulmonary Aortic valve

BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure for Clinical Phenotypes

Webinars

Temporal Changes in Procedural Success and Clinical Outcomes of MTEER by Mechanism of MR: Analysis of the STS/TVT Registry

Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

Overcoming Status Quo Bias: Embracing Evidence-Based Guidelines in Cardiometabolic Care

Percutaneous Revascularisation for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

Additional Data From SEQUOIA-HCM Presented at HFSA Annual Scientific Meeting

Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity

Identification of Fatigue Subtypes and Their Correlates in Prevalent Heart Failure: A Secondary Analysis of the Atherosclerosis Risk in Communities Study

Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction

Incidence, Risk Factors, and Outcomes Associated With Permanent Pacemaker Implantation Following Tricuspid Valve Surgery

The legal case – naming a few names

Chest pain followed by 6 days of increasing dyspnea -- what happened?

Patient is informed of her husband's death: is it OMI or it stress cardiomyopathy?

Right ventricular dysfunction and impaired right ventricular–pulmonary arterial coupling in paradoxical low‐flow, low‐gradient aortic stenosis

Stay Connected